Your browser doesn't support javascript.
loading
Both the subtypes of KIT mutation and minimal residual disease are associated with prognosis in core binding factor acute myeloid leukemia: a retrospective clinical cohort study in single center.
Duan, Wenbing; Liu, Xiaohong; Zhao, Xiaosu; Jia, Jinsong; Wang, Jing; Gong, Lizhong; Jiang, Qian; Zhao, Ting; Wang, Yu; Zhang, Xiaohui; Xu, Lanping; Shi, Hongxia; Chang, Yingjun; Liu, Kaiyan; Huang, Xiaojun; Qin, Yazhen; Jiang, Hao.
Afiliación
  • Duan W; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing, China.
  • Liu X; Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Zhao X; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing, China.
  • Jia J; Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Wang J; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing, China.
  • Gong L; Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Jiang Q; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing, China.
  • Zhao T; Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing, China.
  • Zhang X; Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Xu L; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing, China.
  • Shi H; Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Chang Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing, China.
  • Liu K; Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Huang X; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing, China.
  • Qin Y; Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Jiang H; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing, China.
Ann Hematol ; 100(5): 1203-1212, 2021 May.
Article en En | MEDLINE | ID: mdl-33474629
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Proteínas Proto-Oncogénicas c-kit Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Proteínas Proto-Oncogénicas c-kit Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Alemania